ANNOUNCEMENT

Save $300 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Earlybird rate ends May 20.

Topic: Ann Arbor

Lipitor co-developer’s rebooted startup gets $33M for trials of cholesterol-lowering drug

Lipitor co-developer’s rebooted startup gets $33M for trials of cholesterol-lowering drug

April 30, 2013 5:15 pm by | 0 Comments

In its second wind as a company, Esperion Therapeutics (once owned by Pfizer) has just collected $33 million to continue with clinical trials of its cholesterol-lowering drug.Plymouth, Michigan-based Esperion is ... Read more
Age is just a number: This device takes a new approach to assessing the quality of stored blood

Age is just a number: This device takes a new approach to assessing the quality of stored blood

April 24, 2013 3:32 pm by | 0 Comments

When donors give blood, the components of that blood most commonly used by hospitals, red blood cells, are refrigerated and stored for up to six weeks, at which point it’s ... Read more
Aastrom Biosciences ends drug trial, to cut half its workforce

Aastrom Biosciences ends drug trial, to cut half its workforce

March 27, 2013 9:09 am by | 0 Comments

(Reuters) - Aastrom Biosciences Inc said it would end the late-stage trial of its drug to treat critical limb ischemia - a form of peripheral arterial disease - and cut ... Read more
Retinal degeneration treatment firm raising funds ahead of clinical trials

Retinal degeneration treatment firm raising funds ahead of clinical trials

October 12, 2011 11:02 pm by | 1 Comments

A Michigan company developing a treatment to help restore vision in patients with retinal degeneration hopes to have its lead candidate in clinical trials in 2012.RetroSense Therapeutics, an Ann Arbor ... Read more
Diabetes medical devicemaker seeks up to $2M

Diabetes medical devicemaker seeks up to $2M

December 30, 2010 2:32 pm by | 0 Comments

Hygieia's glucose monitoring system would allow diabetics to adjust the amount of glucose they inject without visiting a doctor. The device provides dose-by-dose insulin recommendations based on their body chemistry ... Read more
Women’s health drugmaker Meditrina seeks fresh funding

Women’s health drugmaker Meditrina seeks fresh funding

December 30, 2010 2:30 pm by | 0 Comments

Meditrina, which is based in Ann Arbor, Michigan, is using patents from AstraZeneca to treat women's health issues including endometriosis and uterine fibroids, which are abnormal growths or tumors that ... Read more
Cardiovascular cell therapy firm Aastrom expands partnership with ATEK Medical

Cardiovascular cell therapy firm Aastrom expands partnership with ATEK Medical

October 27, 2010 8:35 pm by | 0 Comments

"We expect that this collaboration will be a critical advantage for Aastrom as we move our cardiovascular programs into the final stages of clinical development," said Aastrom CEO Tim Mayleben ... Read more
Cerenis Therapeutics adds $13.9M for plaque-reversing heart drug

Cerenis Therapeutics adds $13.9M for plaque-reversing heart drug

October 22, 2010 7:07 pm by | 0 Comments

Ann Arbor, Michigan, biopharmaceutical company Cerenis Therapeutics added $13.9 million to a July investment round that it will use to continue clinical trials of a drug to treat heart disease. ... Read more
Compendia Bioscience gets $1.3M SBIR grant for micro-RNA search

Compendia Bioscience gets $1.3M SBIR grant for micro-RNA search

September 1, 2010 10:58 am by | 0 Comments

Compendia Bioscience Inc. in Ann Arbor, Michigan, has won a $1.3 million Small Business Innovation Research Fast Track award to create a way for scientists to survey micro-RNA data ... Read more
U of Michigan MBA grads launch fund for life science startups

U of Michigan MBA grads launch fund for life science startups

August 27, 2010 3:45 pm by | 0 Comments

Two University of Michigan MBA graduates have formed Resonant Venture Partners in Ann Arbor to invest in seed-stage IT, life sciences, advanced manufacturing, alternative energy and defense companies in their ... Read more
Molecular diagnostics firm Swift Biosciences gets $3M investment

Molecular diagnostics firm Swift Biosciences gets $3M investment

August 12, 2010 10:31 am by | 0 Comments

Molecular diagnostics startup Swift Biosciences Inc. has pulled in a $3 million Series A investment.The Ann Arbor, Michigan-based company will sell molecular biology reagents, which help scientists and doctors conduct ... Read more
Cerenis Therapeutics gets $51M Series C for cardiovascular disease drug

Cerenis Therapeutics gets $51M Series C for cardiovascular disease drug

July 26, 2010 10:47 am by | 0 Comments

Cerenis Therapeutics has pulled in a $51.7 million Series C round to fund Phase 2 trials of a drug that treats cardiovascular disease.The company, with operations in France and Ann ... Read more
Adeona Pharmaceuticals pulls in $1M equity investment

Adeona Pharmaceuticals pulls in $1M equity investment

July 6, 2010 10:51 am by | 0 Comments

Adeona Pharmaceuticals (AMEX: AEN) has received a $1 million equity investment from a Florida private equity firm as the drug developer looks to bring a drug to market for the ... Read more
Plymouth Ventures closes $16M for second fund, looking for more

Plymouth Ventures closes $16M for second fund, looking for more

June 24, 2010 10:42 am by | 0 Comments

Plymouth Venture Partners has closed on $16 million and hopes to at least double that amount before it’s done raising cash for its second fund.After the $16 million close was ... Read more
CytoPherx raises $5M to develop dialysis filters

CytoPherx raises $5M to develop dialysis filters

June 18, 2010 3:11 pm by | 0 Comments

CytoPherx Inc. has raised $5 million of an anticipated $7.5 million Series B round to develop a device that filters the blood of kidney disease patients.The funding will go toward ... Read more